Isthmus Partners LLC Sells 1,063 Shares of Colgate-Palmolive (NYSE:CL)

Isthmus Partners LLC decreased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 0.8% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 134,954 shares of the company’s stock after selling 1,063 shares during the quarter. Colgate-Palmolive accounts for about 1.7% of Isthmus Partners LLC’s investment portfolio, making the stock its 22nd biggest position. Isthmus Partners LLC’s holdings in Colgate-Palmolive were worth $14,010,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. E Fund Management Hong Kong Co. Ltd. bought a new position in shares of Colgate-Palmolive during the second quarter valued at approximately $25,000. Continuum Advisory LLC grew its stake in shares of Colgate-Palmolive by 46.5% during the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after buying an additional 125 shares during the last quarter. Reston Wealth Management LLC bought a new position in shares of Colgate-Palmolive during the third quarter valued at approximately $42,000. Capital Performance Advisors LLP purchased a new stake in shares of Colgate-Palmolive in the third quarter valued at approximately $53,000. Finally, Prospera Private Wealth LLC purchased a new stake in shares of Colgate-Palmolive in the third quarter valued at approximately $64,000. Institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

CL has been the subject of a number of research reports. Stifel Nicolaus lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their price target for the company from $105.00 to $101.00 in a report on Monday, October 28th. UBS Group boosted their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Wells Fargo & Company lowered their price target on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a report on Monday, October 28th. Piper Sandler started coverage on Colgate-Palmolive in a report on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 price target for the company. Finally, Deutsche Bank Aktiengesellschaft lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and upped their target price for the stock from $107.00 to $109.00 in a report on Monday, September 9th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $105.11.

Colgate-Palmolive Price Performance

NYSE CL opened at $96.76 on Friday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The stock’s fifty day moving average price is $97.51 and its 200 day moving average price is $98.57. Colgate-Palmolive has a 1 year low of $75.50 and a 1 year high of $109.30. The company has a market cap of $79.05 billion, a price-to-earnings ratio of 27.73, a PEG ratio of 3.40 and a beta of 0.42.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.07%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s payout ratio is 57.31%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.37% of the stock is owned by insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.